Recombinant IGF1R (Dalotuzumab Biosimilar) antibody

Catalog No. ABIN7487949

This anti-IGF1R (Dalotuzumab Biosimilar) antibody is a Mammalian Cells Monoclonal antibody detecting IGF1R (Dalotuzumab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant IGF1R (Dalotuzumab Biosimilar) antibody (ABIN7487949)

Target: IGF1R (Dalotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IGF1R (Dalotuzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IGF1R (Dalotuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Dalotuzumab Biosimilar - Anti-IGF1R, CD221 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IGF1R (Dalotuzumab Biosimilar)

Target: IGF1R (Dalotuzumab Biosimilar)

Target Type: Biosimilar

Background: MK-0646
Dalotuzumab (MK-0646; h7C10), is a recombinant humanized IgG1 mAb against the IGF1R for the potential intravenous treatment of cancer, including Breast Cancer, Non-Small Cell Lung Cancer, and Metastatic Colorectal Cancer.

CAS-No: 1005389-60-5